NCT00174681View on ClinicalTrials.gov

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

390

Participants

Timeline

Start Date

April 30, 2003

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Glargine

Trial Locations (6)

Unknown

Sanofi-Aventis, Zagreb

Sanofi-Aventis, Prague

Sanofi-Aventis, Paris

Sanofi-Aventis, Bucharest

Sanofi-Aventis, Moscow

Sanofi-Aventis, Ljubljana

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00174681 - Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter